Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
16,738,705
-
Share change
-
-147,084
-
Total reported value
-
$1,171,435,380
-
Put/Call ratio
-
36%
-
Price per share
-
$70.00
-
Number of holders
-
134
-
Value change
-
+$53,742,069
-
Number of buys
-
83
-
Number of sells
-
58
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q3 2016
As of 30 Sep 2016,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,738,705 shares.
The largest 10 holders included
ProQuest Associates IV LLC, JANUS CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, Hudson Executive Capital LP, BlackRock Fund Advisors, VICTORY CAPITAL MANAGEMENT INC, Park West Asset Management LLC, First Eagle Investment Management, LLC, STATE STREET CORP, and JW Asset Management, LLC.
This page lists
134
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.